1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

NodThera Limited

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2016

Location

Cambridge UK

Primary Industry

Biotechnology

About

Founded in 2016 and based in Cambridge, UK, NodThera Limited operates as a developer of NRLP3, an inflammasome activation inhibitors for the treatment of chronic inflammation.
Current Investors
Sofinnova Partners, 5AM Ventures, F-Prime Capital

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.nodthera.com
Company Stage
Series B
Total Amount Raised
Subscriber access only

Timeline of Key Events

TimeLine Events

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin
31 Dec 2018
0
-
(4,868,563)
-
(4,862,542)
-
(4,132,502)
-
31 Dec 2019
31 Dec 2020
31 Dec 2021

Unlock the recent years of financials and more for NodThera Limited.

Request a demo to see more.

Employee Data

Employee Graph

Want to see the Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.